J Robert Kerrey Sells 12,010 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director J. Robert Kerrey sold 12,010 shares of the company’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the transaction, the director owned 4,794 shares in the company, valued at approximately $1,264,273.68. The trade was a 71.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Tenet Healthcare Stock Up 1.8%

Shares of THC traded up $4.71 on Wednesday, reaching $265.56. The company’s stock had a trading volume of 628,981 shares, compared to its average volume of 705,306. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $283.05. The stock has a market capitalization of $21.38 billion, a PE ratio of 10.24, a PEG ratio of 0.99 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The firm has a fifty day moving average of $248.41 and a 200-day moving average of $212.79.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same period in the previous year, the company posted $4.02 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities analysts predict that Tenet Healthcare Corporation will post 21.04 EPS for the current year.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently added to or reduced their stakes in THC. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $29,000. Trust Co. of Vermont bought a new position in Tenet Healthcare during the second quarter valued at $37,000. OP Asset Management Ltd bought a new stake in shares of Tenet Healthcare in the first quarter valued at $49,000. Compass Financial Management LLC purchased a new position in shares of Tenet Healthcare during the 2nd quarter valued at $57,000. Finally, William B. Walkup & Associates Inc. grew its stake in shares of Tenet Healthcare by 88.7% during the 4th quarter. William B. Walkup & Associates Inc. now owns 302 shares of the company’s stock worth $60,000 after acquiring an additional 142 shares during the period. Institutional investors own 95.44% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on THC. Royal Bank Of Canada lifted their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a report on Monday, July 27th. Piper Sandler set a $308.00 price target on shares of Tenet Healthcare in a report on Monday, July 27th. Morgan Stanley increased their price objective on shares of Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research note on Monday, July 27th. Mizuho set a $290.00 target price on shares of Tenet Healthcare in a research report on Monday, August 10th. Finally, Zacks Research raised Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $275.53.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong analyst and quantitative support: Zacks highlighted Tenet among hospital operators benefiting from steady healthcare demand and improved efficiency. THC was also added to Zacks’ Rank #1 “Strong Buy” lists for both growth and value stocks, reinforcing the view that its earnings outlook and valuation remain attractive. 3 Hospital Stocks Riding Strong Demand and Improved Efficiency Best Growth Stocks to Buy for September 16th Best Value Stocks to Buy for September 16th
• Positive Sentiment: Potential undervaluation and earnings momentum: Zacks’ latest analysis points to favorable value, growth and momentum characteristics. That view is supported by Tenet’s latest quarterly results, which exceeded earnings and revenue estimates, with revenue increasing year over year. Are Investors Undervaluing Tenet Healthcare
• Positive Sentiment: Ambulatory strategy remains a strength: Coverage of United Surgical Partners International, Tenet’s ambulatory surgery platform, keeps attention on outpatient care, an area that can support more efficient growth and portfolio optimization. Tenet’s full-year 2026 EPS guidance and predominantly positive analyst ratings also support the bullish case. 5 Things to Know About United Surgical Partners International
• Neutral Sentiment: Restructuring creates mixed implications: Tenet’s $2.7 billion Conifer breakup is reportedly leading to 1,037 job cuts. The separation could streamline operations and sharpen strategic focus, but the near-term workforce reduction highlights execution and restructuring risks. Tenet’s $2.7B Conifer Breakup Triggers 1,037 Job Cuts
• Negative Sentiment: Director stock sale: Director Richard Mark sold 10,000 THC shares for approximately $2.6 million, reducing his position by 28.47%. The transaction is relatively small compared with Tenet’s market value but may weigh modestly on sentiment because it represents insider selling. Richard Mark Sells 10,000 Shares of Tenet Healthcare

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.